G. Mahn and E.L. Baker. “Patent infringement at the ITC: implications for brand-name drug companies,” Pharmaceutical Compliance Monitor (September 2015)
G. Mahn and E.L. Baker. “The efficiency of bringing drugs to market versus the fairness of making drugs accessible,” Pharmaceutical Compliance Monitor (October 2014)
G. Mahn and E.L. Baker. “Is the safe harbor too safe for certain biologic patents?” Pharmaceutical Compliance Monitor (August 2013)
L. Baker, J. Srivastava, D. Yu, R.T. Bonnecaze, and M.H. Zaman. “Cancer cell motility: integrated roles of matrix mechanics and transforming potential,” PLOS ONE (May 2011)
L. Baker, J. Lu, D. Yu, R.T. Bonnecaze, and M.H. Zaman. “Cancer cell stiffness: integrated roles of 3-dimensional matrix stiffness and transforming potential,” Biophysical Journal (October 2010)
L. Baker and M.H. Zaman. “The biomechanical integrin,” Journal of Biomechanics (January 2010)
L. Baker, R.T. Bonnecaze, and M.H. Zaman. “Extracellular matrix stiffness and architecture govern intracellular rheology in cancer,” Biophysical Journal (August 2009)
L. Baker, R.G. Dennis, and L.M. Larkin. “Glucose transporter content and glucose uptake in skeletal muscle constructs engineered in vitro,” In Vitro Cellular & Developmental Biology-Animal(November 2003)
Media mentions
“Influential Blacks in Tech,” Austin Black Business Journal & Community News Magazine (September 2019)
“Rising Stars” Issue, Diversity & the Bar Magazine (June 2017)
“Cancer cell motility: integrated roles of matrix mechanics and transforming potential,” PLOS ONE (2007)
